Response-Adapted Therapy with Nivolumab and Brentuximab Vedotin (BV), Followed By BV and Bendamustine for Suboptimal Response, in Children, Adolescents, and Young Adults with Standard-Risk Relapsed/Refractory Classical Hodgkin Lymphoma

著录项

• 来源
  《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共3页
• 作者

  Harker-Murray Paul; Leblanc Thierry; Mascarin Maurizio; Mauz-Koerholz Christine; Michel Gerard; Cooper Stacy; Beishuizen Auke; Leger Kasey J.; Garaventa Alberto; Buffardi Salvatore; Brugieres Laurence; Kelly Kara M.; Cole Peter D.; Drachtman Richard A.; Galderisi Faith; Sacchi Mariana; Jou Ying-Ming; Daw Stephen;

  展开▼
• 作者单位

  Childrens Hosp Wisconsin Milwaukee WI 53201 USA;

  Hop Robert Debre APHP Paris France;

  IRCCS Ctr Riferimento Oncol Aviano Italy;

  Justus Liebig Univ Univ Hosp Giessen Germany;

  Hop la Timone Marseille France;

  Johns Hopkins Univ Hosp Baltimore MD 21287 USA;

  Princess Maxima Ctr Pediat Oncol Utrecht Netherlands;

  Seattle Childrens Hosp Seattle WA USA;

  Osped Giannina Gaslini Genoa Italy;

  Santobono Pausilipon Hosp Naples Italy;

  Inst Gustave Roussy Villejuif France;

  Roswell Pk Canc Inst Buffalo NY 14263 USA;

  Robert Wood Johnson Med Sch Piscataway NJ USA;

  Rutgers Canc Inst New Jersey New Brunswick NJ USA;

  Seattle Genet Inc Bothell WA USA;

  Bristol Myers Squibb Princeton NJ USA;

  Bristol Myers Squibb Princeton NJ USA;

  Univ Coll Hosp London England;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 血液及淋巴系疾病;
• 关键词